These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21565696)

  • 41. SH2 binding site comparison: a new application of the SURFCOMP method.
    Hofbauer C; Aszódi A
    J Chem Inf Model; 2005; 45(2):414-21. PubMed ID: 15807507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural clusters of evolutionary trace residues are statistically significant and common in proteins.
    Madabushi S; Yao H; Marsh M; Kristensen DM; Philippi A; Sowa ME; Lichtarge O
    J Mol Biol; 2002 Feb; 316(1):139-54. PubMed ID: 11829509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting protein-ligand binding affinities: a low scoring game?
    Marsden PM; Puvanendrampillai D; Mitchell JB; Glen RC
    Org Biomol Chem; 2004 Nov; 2(22):3267-73. PubMed ID: 15534704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SimG: an alignment based method for evaluating the similarity of small molecules and binding sites.
    Cai C; Gong J; Liu X; Gao D; Li H
    J Chem Inf Model; 2013 Aug; 53(8):2103-15. PubMed ID: 23889471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blind predictions of protein interfaces by docking calculations in CAPRI.
    Lensink MF; Wodak SJ
    Proteins; 2010 Nov; 78(15):3085-95. PubMed ID: 20839234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein-protein docking tested in blind predictions: the CAPRI experiment.
    Janin J
    Mol Biosyst; 2010 Dec; 6(12):2351-62. PubMed ID: 20725658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting protein-ligand binding site using support vector machine with protein properties.
    Wong GY; Leung FH; Ling SH
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1517-29. PubMed ID: 24407309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unbiased binding assays for discovering small-molecule probes and drugs.
    Kemp MM; Weïwer M; Koehler AN
    Bioorg Med Chem; 2012 Mar; 20(6):1979-89. PubMed ID: 22230199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure-based computational analysis of protein binding sites for function and druggability prediction.
    Nisius B; Sha F; Gohlke H
    J Biotechnol; 2012 Jun; 159(3):123-34. PubMed ID: 22197384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological and functional relevance of CASP predictions.
    Liu T; Ish-Shalom S; Torng W; Lafita A; Bock C; Mort M; Cooper DN; Bliven S; Capitani G; Mooney SD; Altman RB
    Proteins; 2018 Mar; 86 Suppl 1(Suppl Suppl 1):374-386. PubMed ID: 28975675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular fields in ligand discovery.
    Gane PJ; Chan AW
    Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FINDSITE: a threading-based approach to ligand homology modeling.
    Brylinski M; Skolnick J
    PLoS Comput Biol; 2009 Jun; 5(6):e1000405. PubMed ID: 19503616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemogenomics in drug discovery: computational methods based on the comparison of binding sites.
    Vulpetti A; Kalliokoski T; Milletti F
    Future Med Chem; 2012 Oct; 4(15):1971-9. PubMed ID: 23088277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FINDSITE
    Zhou H; Cao H; Skolnick J
    J Chem Inf Model; 2018 Nov; 58(11):2343-2354. PubMed ID: 30278128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absolute Alchemical Free Energy Calculations for Ligand Binding: A Beginner's Guide.
    Aldeghi M; Bluck JP; Biggin PC
    Methods Mol Biol; 2018; 1762():199-232. PubMed ID: 29594774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the complementarity of the consensus-based disorder prediction.
    Peng Z; Kurgan L
    Pac Symp Biocomput; 2012; ():176-87. PubMed ID: 22174273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and validation of bioactive small molecule target through phenotypic screening.
    Cho YS; Kwon HJ
    Bioorg Med Chem; 2012 Mar; 20(6):1922-8. PubMed ID: 22153994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Target identification of bioactive compounds.
    Tashiro E; Imoto M
    Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hot spots and transient pockets: predicting the determinants of small-molecule binding to a protein-protein interface.
    Metz A; Pfleger C; Kopitz H; Pfeiffer-Marek S; Baringhaus KH; Gohlke H
    J Chem Inf Model; 2012 Jan; 52(1):120-33. PubMed ID: 22087639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting protein-ligand binding sites based on an improved geometric algorithm.
    He J; Wei DQ; Wang JF; Chou KC
    Protein Pept Lett; 2011 Oct; 18(10):997-1001. PubMed ID: 21592081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.